Woodline Partners LP Eye Point Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 500,335 shares of EYPT stock, worth $5.38 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
500,335
Previous 500,335
-0.0%
Holding current value
$5.38 Million
Previous $2.71 Million
73.66%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
159Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$89.5 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$73.1 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$73.1 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$49.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$46.2 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $366M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...